Vanguard Group Inc Savara Inc Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Savara Inc stock. As of the latest transaction made, Vanguard Group Inc holds 8,119,247 shares of SVRA stock, worth $16.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,119,247

Previous 8,309,970 2.3%

Holding current value

$16.2 Million

Previous $25.5 Million 11.84%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$2.32 - $3.14 $442,477 - $598,870	-190,723 Reduced 2.3%	8,119,247 $22.5 Million
Q4 2024 Feb 11, 2025	BUY	$2.94 - $4.07 $1.08 Million - $1.49 Million	365,959 Added 4.61%	8,309,970 $25.5 Million
Q3 2024 Nov 13, 2024	BUY	$3.96 - $5.07 $5.17 Million - $6.62 Million	1,305,253 Added 19.66%	7,944,011 $33.7 Million
Q2 2024 Aug 13, 2024	BUY	$3.66 - $5.34 $2.11 Million - $3.07 Million	575,138 Added 9.49%	6,638,758 $26.8 Million
Q1 2024 May 10, 2024	BUY	$4.19 - $5.59 $622,939 - $831,082	148,673 Added 2.51%	6,063,620 $30.2 Million
Q4 2023 Feb 14, 2024	BUY	$3.18 - $4.9 $478,100 - $736,695	150,346 Added 2.61%	5,914,947 $27.8 Million
Q3 2023 Nov 14, 2023	BUY	$2.97 - $3.88 $2.34 Million - $3.06 Million	789,249 Added 15.86%	5,764,601 $21.8 Million
Q2 2023 Aug 14, 2023	BUY	$1.69 - $3.24 $420,267 - $805,719	248,679 Added 5.26%	4,975,352 $15.9 Million
Q1 2023 May 15, 2023	SELL	$1.6 - $2.82 $127,840 - $225,318	-79,900 Reduced 1.66%	4,726,673 $9.22 Million
Q4 2022 Feb 10, 2023	BUY	$1.11 - $1.64 $1,694 - $2,504	1,527 Added 0.03%	4,806,573 $7.45 Million
Q3 2022 Nov 14, 2022	SELL	$1.36 - $1.88 $651 - $900	-479 Reduced 0.01%	4,805,046 $7.45 Million
Q2 2022 Aug 12, 2022	SELL	$1.1 - $1.58 $15,068 - $21,644	-13,699 Reduced 0.28%	4,805,525 $7.3 Million
Q1 2022 May 13, 2022	SELL	$1.05 - $1.36 $21,800 - $28,236	-20,762 Reduced 0.43%	4,819,224 $6.31 Million
Q4 2021 Feb 14, 2022	BUY	$1.04 - $1.34 $361,648 - $465,970	347,739 Added 7.74%	4,839,986 $6 Million
Q2 2021 Aug 13, 2021	BUY	$1.51 - $2.29 $6.78 Million - $10.3 Million	4,492,247 New	4,492,247 $7.64 Million

Others Institutions Holding SVRA

# of Institutions

143

Shares Held

162M

Call Options Held

54.8K

Put Options Held

4.1K

View Full List

About Savara Inc

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $227M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

More about SVRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Savara Inc Transaction History